Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population

Metabolism: Clinical and Experimental

Volumn 56, Issue 4, 2007, Pages 552-558

  Choi, Kyung Mook ^a   Kim, Seon Mee ^b   Kim, Yeong Eun ^b   Choi, Dong Seop ^a   Baik, Sei Hyun ^a   Lee, Juneyoung ^b  

^a Department of Internal Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; STROKE;

ADULT; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; KOREA; MALE; METABOLIC SYNDROME X; PATIENT EDUCATION; PREVALENCE; RISK FACTORS;

EID: 33947229535     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.12.003     Document Type: Article

References (25)

1. Dunstan D.W., Zimmet P.Z., Welborn T.A., et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study. Diabetes Care 25 (2002) 829-834
2. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
3. Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173 (2004) 309-314
4. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
5. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
6. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16 (1999) 442-443
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA 285 (2001) 2486-2497
8. Einhorn D., Reaven G.M., Cobin R.H., et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9 (2003) 237-252
9. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
10. Tan C.E., Ma S., Wai D., et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 27 (2004) 1182-1186
11. Ford E.S. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 33 (2004) 333-350
12. IDF. The IDF consensus worldwide definition of the metabolic syndrome. Available from. http://www.idf.org/webdata/docs/Metabolic_Syndrome_Definition.pdf [accessible at Nov. 10, 2005]
13. Kim S.M., Lee J.S., Lee J., et al. Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. Diabetes Care 29 (2006) 226-231
14. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
15. Steering Committee. The Asia-Pacific perspective: redefining obesity and its treatment (2000), Diabetes Institute, Melbourne, Australia, International
16. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
17. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28 (2005) 2745-2749
18. Adams R.J., Appleton S., Wilson D.H., et al. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care 28 (2005) 2777-2779
19. Molarius A., Seidell J.C., Sans S., et al. Varying sensitivity of waist action levels to identify subjects with overweight or obesity in 19 populations of the WHO MONICA Project. J Clin Epidemiol 52 (1999) 1213-1224
20. Patel S., Unwin N., Bhopal R., et al. A comparison of proxy measures of abdominal obesity in Chinese, European and South Asian adults. Diabet Med 16 (1999) 853-860
21. Misra A., Wasir J.S., and Vikram N.K. Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. Nutrition 21 (2005) 969-976
22. Lohsoonthorn V., Dhanamun B., and Williams M.A. Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations. Am J Hypertens 19 (2006) 339-345
23. Gu D., Reynolds K., Wu X., et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
24. Byrt T. How good is that agreement?. Epidemiology 7 (1996) 561
25. Ford E.S., and Giles W.H. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26 (2003) 575-581